Opko Health Inc (OPK) Stock Price, Quote & News

Company Profile

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 305 575 4100

Website: www.opko.com

Address:

4400 Biscayne Boulevard, Miami, United States

Gasbagger Apr. 3 at 7:12 PM

$OPK Frost bought BRLI with Opko stock,no cash at all involved. He then sells two thirds of it for over 600 million in cash . The Longs get zero in return for their original investment. Plus all the revenues Brli generated disappeared.

0 · Reply

Gasbagger Apr. 3 at 4:35 PM

$OPK has enough cash to fund its operations for another 2 years. Why would they ever do a stock buy back when theyre going to evenually dilute the stock to raise cash.

0 · Reply

Gasbagger Apr. 3 at 3:06 PM

$OPK This is an Opko board not a COCP one.

0 · Reply

tymtested Apr. 2 at 7:39 PM

$OPK Shares of Cocrystal Pharma Inc(COCP)got a boost, surging 36% to $1.38 after the company announced that it has received Fast Track designation from the FDA for its CDI-988, the first oral antiviral candidate being developed for treatment and prophylaxis of norovirus infection

0 · Reply

Gasbagger Apr. 2 at 5:04 PM

$OPK Management has turned a 7 billion dollar mkt cap into under 1 billion.

2 · Reply

LongAllDay Apr. 2 at 4:43 PM

$OPK LAMEST STOCK OF THE ROARING 20’s

0 · Reply

Gasbagger Apr. 2 at 4:00 PM

$OPK No updates from ModeX. This is what happens when its nothing more than a R&D money grab.

0 · Reply

Brasil07 Apr. 2 at 1:38 PM

$OPK Cochrystal +81% when Frost Will decide to meke the same for this garbage?

0 · Reply

tymtested Apr. 2 at 12:26 PM

$OPK there is no proof of opko owing $250 M to Israel

0 · Reply

Gasbagger Apr. 2 at 3:39 AM

$OPK when will Opko pay the 250 million it owes the Israeli Gvt ?

1 · Reply

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

Feb 26, 2026, 8:57 PM EST - 5 weeks ago

OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 4:05 PM EST - 5 weeks ago

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

Feb 12, 2026, 8:00 AM EST - 7 weeks ago

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26

Feb 4, 2026, 8:00 AM EST - 2 months ago

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

Jan 27, 2026, 4:03 AM EST - 2 months ago

OPKO Health: Deeply Mispriced Ahead Of Major Catalysts

Jan 15, 2026, 5:45 AM EST - 2 months ago

OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 6, 2026, 4:11 PM EST - 3 months ago

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Nov 19, 2025, 4:05 PM EST - 4 months ago

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

Oct 29, 2025, 9:36 PM EDT - 5 months ago

OPKO Health, Inc. (OPK) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:05 PM EDT - 5 months ago

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

Oct 22, 2025, 4:05 PM EDT - 5 months ago

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

Sep 15, 2025, 8:30 AM EDT - 7 months ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Jul 31, 2025, 9:19 PM EDT - 8 months ago

OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 4:05 PM EDT - 8 months ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

Jun 30, 2025, 8:01 AM EDT - 9 months ago

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL

Jun 25, 2025, 11:00 AM EDT - 10 months ago

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

May 15, 2025, 8:00 AM EDT - 11 months ago

OPKO Health to Participate in Two Upcoming Investor Conferences

Apr 30, 2025, 7:52 PM EDT - 1 year ago

OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

Apr 4, 2025, 8:00 AM EDT - 1 year ago

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Mar 17, 2025, 8:57 AM EDT - 1 year ago

OPKO and Entera partner to develop obesity pill

Mar 11, 2025, 7:00 AM EDT - 1 year ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Feb 27, 2025, 7:12 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:10 PM EST - 1 year ago

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Jan 9, 2025, 11:45 AM EST - 1 year ago

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 18, 2024, 8:00 AM EST - 1 year ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

NXPL

Nov 14, 2024, 6:00 AM EST - 1 year ago

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

BABA NXPL

Nov 7, 2024, 8:30 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

Oct 7, 2024, 8:00 AM EDT - 1 year ago

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Oct 7, 2024, 8:00 AM EDT - 1 year ago

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

NXPL

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Aug 7, 2024, 4:06 PM EDT - 1 year ago

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

Jul 17, 2024, 4:14 PM EDT - 1 year ago

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

May 31, 2024, 10:48 AM EDT - 2 years ago

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 7, 2024, 8:03 PM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 2 years ago

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

May 3, 2024, 8:00 AM EDT - 2 years ago

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 28, 2024, 8:00 AM EDT - 2 years ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Mar 5, 2024, 8:52 AM EST - 2 years ago

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

Feb 27, 2024, 8:08 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 2 years ago

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Feb 22, 2024, 4:05 PM EST - 2 years ago

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Jan 9, 2024, 4:05 PM EST - 2 years ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

Jan 4, 2024, 11:31 PM EST - 2 years ago

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Jan 3, 2024, 5:05 PM EST - 2 years ago

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

Nov 28, 2023, 7:00 AM EST - 2 years ago

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

Nov 7, 2023, 6:45 AM EST - 2 years ago

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPH

Nov 6, 2023, 7:32 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 4:05 PM EST - 2 years ago

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 2, 2023, 10:00 AM EDT - 2 years ago

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Gasbagger Apr. 3 at 7:12 PM

0 · Reply

Gasbagger Apr. 3 at 4:35 PM

$OPK has enough cash to fund its operations for another 2 years. Why would they ever do a stock buy back when theyre going to evenually dilute the stock to raise cash.

0 · Reply

Gasbagger Apr. 3 at 3:06 PM

$OPK This is an Opko board not a COCP one.

0 · Reply

tymtested Apr. 2 at 7:39 PM

0 · Reply

Gasbagger Apr. 2 at 5:04 PM

$OPK Management has turned a 7 billion dollar mkt cap into under 1 billion.

2 · Reply

LongAllDay Apr. 2 at 4:43 PM

$OPK LAMEST STOCK OF THE ROARING 20’s

0 · Reply

Gasbagger Apr. 2 at 4:00 PM

$OPK No updates from ModeX. This is what happens when its nothing more than a R&D money grab.

0 · Reply

Brasil07 Apr. 2 at 1:38 PM

$OPK Cochrystal +81% when Frost Will decide to meke the same for this garbage?

0 · Reply

tymtested Apr. 2 at 12:26 PM

$OPK there is no proof of opko owing $250 M to Israel

0 · Reply

Gasbagger Apr. 2 at 3:39 AM

$OPK when will Opko pay the 250 million it owes the Israeli Gvt ?

1 · Reply

Gasbagger Apr. 2 at 12:57 AM

$OPK I wonder how many of those shares that the Long Term Bond Holder received by Opko has left? They received over 121 million shares as part of his payment for those Long Term Notes .

0 · Reply

Sierradude Apr. 1 at 7:10 PM

$OPK These guys run their mouth about shareholder value every damned quarter. Look at this POS.... unbelievable

2 · Reply

Mike18181 Mar. 30 at 9:33 PM

$OPK to present at the Florida growth stock symposium. Opko has been growing in Reverse of 20% annual for the past 3 years. " we are pleased to announce that not long from now we will be havibg total revenues of 100 million. We keep getting smaller,and smaller and smaller. Our hard work and BS has devalued the shares to a BUCK. We aeven get bonuses for this. We look forward to communicating as we will get Milestone payments. If we go under a $1.00 a share and delisted to Otcbb, we will get a substantial bonus...

1 · Reply

tymtested Mar. 30 at 7:39 PM

$OPK OPKO differs from typical biotech

0 · Reply

Brasil07 Mar. 30 at 7:04 PM

$OPK no the only One opportunity for us, Is when Frost passed away....( I Hope as soon as possible)

1 · Reply

tymtested Mar. 30 at 6:43 PM

$OPK Is war creating an opportunity for OPKO's stock buyback program?

0 · Reply

tymtested Mar. 30 at 4:45 PM

$OPK Huge opportunity to buy shares at prices lower than Dr Frost!!

0 · Reply

magadog Mar. 30 at 2:01 PM

$OPK O look, another day no one even looks at this worthless casino stock..

0 · Reply

Mike18181 Mar. 29 at 9:11 PM

$OPK You have No shareholder return because Frost is Crooked CEO and Un-fit to lead.

0 · Reply

tradertrash Mar. 28 at 10:17 PM

$OPK eirgen, 2 parts of the labs, gdx, covid massive testing, What's the next part to sell ❓ and run-it-back thru the ol r&d money grinder ❓ that's not profits for sh, it's the ol frosty r&d two step 🤡

0 · Reply

Mike18181 Mar. 28 at 6:30 PM

$OPK Frost will take it private after it hit .80 and buy it for 600m to 700m and sell it to Modex boys

0 · Reply

Mike18181 Mar. 28 at 3:09 PM

$OPK Buy ! @ 1.01

0 · Reply

Market Cap	865.34M
Revenue (ttm)	606.88M
Net Income (ttm)	-225.68M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-37.19%
Debt to Equity Ratio	0.27

Volume	1,157,800
Avg Vol	2,686,600
Day's Range	N/A - N/A
Shares Out	759.07M
Stochastic %K	43%
Beta	1.49
Analysts	Strong Sell
Price Target	$2.38